Authors
Coward, JKulbe, H
Chakravarty, P
Leader, D
Vassileva, V
Leinster, D A
Thompson, R
Schioppa, T
Nemeth, J
Vermeulen, J
Singh, N
Avril, N
Cummings, Jeffrey
Rexhepaj, E
Jirström, K
Gallagher, W M
Brennan, D J
McNeish, I A
Balkwill, F R
Affiliation
Barts Cancer Institute, Queen Mary University of London, UK.Issue Date
2011-09-15
Metadata
Show full item recordAbstract
We investigated whether inhibition of interleukin 6 (IL-6) has therapeutic activity in ovarian cancer via abrogation of a tumor-promoting cytokine network.Citation
Interleukin-6 as a therapeutic target in human ovarian cancer. 2011, 17 (18):6083-96 Clin. Cancer Res.Journal
Clinical Cancer ResearchDOI
10.1158/1078-0432.CCR-11-0945PubMed ID
21795409Type
ArticleLanguage
enISSN
1078-0432ae974a485f413a2113503eed53cd6c53
10.1158/1078-0432.CCR-11-0945